Anti-Counterfeiting Trade Agreement Seeks To Exclude Patent Enforcement
This article was originally published in PharmAsia News
Executive Summary
When the U.S. and other countries began negotiating the terms of the Anti-Counterfeiting Trade Agreement, the generic industry was worried that it might be used to expand the rights of patent owners